SCHEMBL5658501

SCHEMBL5658501

Cc1cc(C2(c3ccc(O)c(C)c3)C(=O)N(Cc3ccccc3)c3ccccc32)ccc1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.52
GPR55 Q9Y2T6 1/20 0.52
ALDH1A1 P00352 7/20 0.49
MAPT P10636 3/20 0.49
NPSR1 Q6W5P4 3/20 0.49
MEN1 O00255 2/20 0.49
LMNA P02545 2/20 0.49
KMT2A Q03164 2/20 0.49
XBP1 P17861 1/20 0.49
ESR1 P03372 1/20 0.49
ESR2 Q92731 1/20 0.49
SCN9A Q15858 4/20 0.48
TP53 P04637 3/20 0.48
HSD17B10 Q99714 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
USP2 O75604 1/20 0.45
MAPK1 P28482 1/20 0.45
P2RX1 P51575 1/20 0.45
P2RX3 P56373 1/20 0.45
P2RX4 Q99571 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658990 0.87 CNR1 (0.54) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5659203 0.86 CNR1 (0.52) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5660616 0.85 CNR1 (0.61) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5658420 0.84 MAPT (0.49) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL14457619 0.79 CNR1 (0.47) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL14457581 0.79 SCN9A (0.51) CNR1GPR55ALDH1A1MAPTLMNA
SCHEMBL5658318 0.79 SCN9A (0.52) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5659155 0.78 MAPT (0.50) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5659213 0.77 CNR1 (0.46) CNR1GPR55ALDH1A1MAPTNPSR1
SCHEMBL5659599 0.77 SCN9A (0.58) CNR1GPR55MAPTLMNASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-7250442-B2 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2007-07-31 US disclosed
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054712-A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators NR3C2, NR5A1, NR5A2 CNR1 362/4885GPR55 77/4885ALDH1A1 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.